Postinjection delirium/sedation syndrome in a transgender man undergoing hormone therapy

BACKGROUND: Long-acting injectable medications have become an important tool in the treatment of schizophrenia and schizoaffective disorder due to the high rates of medication nonadherence. Olanzapine long-acting injection (OLAI) is a useful therapeutic option for patients who have good tolerability...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerving, Joshua, Walser, Heather, Kelly, Anne C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Psychiatric Pharmacists 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405634/
https://www.ncbi.nlm.nih.gov/pubmed/36071735
http://dx.doi.org/10.9740/mhc.2022.08.263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405634/
https://www.ncbi.nlm.nih.gov/pubmed/36071735
http://dx.doi.org/10.9740/mhc.2022.08.263

Ejemplares similares